Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPIDS-P: Smoflipid for Sepsis
NCT03405870Phase 2Completed
- Sponsor
- University of Florida
- Start
- Aug 2018
- Primary completion
- Apr 2023
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of SMOFlipid in sepsis, sponsored by University of Florida. Started Aug 2018; status: completed.
02
Drugs
SMOFlipid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03405870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405870.